XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Adjustment
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Adjustment
Beginning balance (in shares) at Dec. 31, 2020     273,537,218        
Beginning balance at Dec. 31, 2020 $ 2,037,143 $ (1,522) $ 2 $ 2,838,057 $ (3,418) $ (797,498) $ (1,522)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from employee equity plans (in shares)     6,831,982        
Issuance of common stock from exercise of stock options 38,059     38,059      
Issuance of common stock for settlement of RSUs (in shares)     1,807,844        
Stock‑based compensation expense 151,961     151,961      
Net loss (255,802)         (255,802)  
Other comprehensive loss (56)       (56)    
Ending balance (in shares) at Jun. 30, 2021     282,177,044        
Ending balance at Jun. 30, 2021 1,969,783   $ 2 3,028,077 (3,474) (1,054,822)  
Beginning balance (in shares) at Mar. 31, 2021     279,170,161        
Beginning balance at Mar. 31, 2021 2,017,212   $ 2 2,927,242 (3,552) (906,480)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from employee equity plans (in shares)     2,287,484        
Issuance of common stock from exercise of stock options 15,435     15,435      
Issuance of common stock for settlement of RSUs (in shares)     719,399        
Stock‑based compensation expense 85,400     85,400      
Net loss (148,342)         (148,342)  
Other comprehensive loss 78       78    
Ending balance (in shares) at Jun. 30, 2021     282,177,044        
Ending balance at Jun. 30, 2021 1,969,783   $ 2 3,028,077 (3,474) (1,054,822)  
Beginning balance (in shares) at Dec. 31, 2021     292,592,356        
Beginning balance at Dec. 31, 2021 $ 2,394,391   $ 2 3,729,874 (3,858) (1,331,627)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from employee equity plans (in shares) 3,038,757   3,246,743        
Issuance of common stock from exercise of stock options $ 37,718     37,718      
Issuance of common stock for settlement of RSUs (in shares)     2,019,132        
Common stock issued in connection with acquisitions (in shares)     169,321        
Common stock issued in connection with acquisitions 16,072     16,072      
Stock‑based compensation expense 221,669     221,669      
Net loss (381,713)         (381,713)  
Other comprehensive loss (6,066)       (6,066)    
Ending balance (in shares) at Jun. 30, 2022     298,027,552        
Ending balance at Jun. 30, 2022 2,282,071   $ 2 4,005,333 (9,924) (1,713,340)  
Beginning balance (in shares) at Mar. 31, 2022     295,846,751        
Beginning balance at Mar. 31, 2022 2,362,142   $ 2 3,879,589 (8,267) (1,509,182)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from employee equity plans (in shares)     1,086,699        
Issuance of common stock from exercise of stock options 7,502     7,502      
Issuance of common stock for settlement of RSUs (in shares)     1,094,102        
Stock‑based compensation expense 118,242     118,242      
Net loss (204,158)         (204,158)  
Other comprehensive loss (1,657)       (1,657)    
Ending balance (in shares) at Jun. 30, 2022     298,027,552        
Ending balance at Jun. 30, 2022 $ 2,282,071   $ 2 $ 4,005,333 $ (9,924) $ (1,713,340)